These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 3708599

  • 1. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
    Teychenne PF, Bergsrud D, Elton RL, Racy A.
    Clin Neuropharmacol; 1986; 9(2):138-45. PubMed ID: 3708599
    [Abstract] [Full Text] [Related]

  • 2. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
    Grimes JD, Delgado MR.
    Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of administration of low doses of bromocriptine and levodopa in the early treatment of Parkinson disease].
    Sternić N, Kostić V.
    Srp Arh Celok Lek; 1992; 120(1-2):1-5. PubMed ID: 1641693
    [Abstract] [Full Text] [Related]

  • 4. Bromocriptine in Parkinson disease.
    Lieberman AN, Goldstein M.
    Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
    de Yébenes JG, García-Ruiz PJ, Sánchez-Pernaute R.
    Rev Neurol; 1997 Sep; 25(145):1343-5. PubMed ID: 9377286
    [Abstract] [Full Text] [Related]

  • 7. The Sydney multicentre study of Parkinson's disease. The first 18 months.
    Hely MA, Morris JG, Rail D, O'Sullivan DJ, Williamson PM, Genge S, Reid WG, Broe GA.
    Med J Aust; 1987 Feb 16; 146(4):195-8. PubMed ID: 3553878
    [Abstract] [Full Text] [Related]

  • 8. The addition of bromocriptine to long-term dopa therapy in Parkinson's disease.
    Selby G.
    Clin Exp Neurol; 1989 Feb 16; 26():129-39. PubMed ID: 2701877
    [Abstract] [Full Text] [Related]

  • 9. Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.
    Jansen EN, Meerwaldt JD.
    Adv Neurol; 1987 Feb 16; 45():539-42. PubMed ID: 3103396
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low-dose bromocriptine in the early phases of Parkinson's disease.
    Tolosa E, Blesa R, Bayes A, Forcadell F.
    Clin Neuropharmacol; 1987 Apr 16; 10(2):168-74. PubMed ID: 3332610
    [Abstract] [Full Text] [Related]

  • 13. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
    Im JH, Ha JH, Cho IS, Lee MC.
    J Neurol; 2003 Jan 16; 250(1):90-6. PubMed ID: 12527999
    [Abstract] [Full Text] [Related]

  • 14. Low-dose, slow-increase bromocriptine in patients with progressive Parkinson's disease and complications of levodopa therapy.
    Stern MB, Vernon GM, Gollomp SM, Hurtig HI.
    Bull Clin Neurosci; 1986 Jan 16; 51():52-6. PubMed ID: 3455244
    [Abstract] [Full Text] [Related]

  • 15. Treatment of parkinson's disease with bromocriptine.
    Lieberman A, Kupersmith M, Estey E, Goldstein M.
    N Engl J Med; 1976 Dec 16; 295(25):1400-4. PubMed ID: 989885
    [Abstract] [Full Text] [Related]

  • 16. Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study.
    van der Drift JH.
    Adv Neurol; 1987 Dec 16; 45():529-34. PubMed ID: 3825731
    [Abstract] [Full Text] [Related]

  • 17. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
    Giménez-Roldán S, Tolosa E, Burguera JA, Chacón J, Liaño H, Forcadell F.
    Clin Neuropharmacol; 1997 Feb 16; 20(1):67-76. PubMed ID: 9037575
    [Abstract] [Full Text] [Related]

  • 18. [Bromocriptine as the 1st treatment of Parkinson's disease. Long term results].
    Rascol A, Montastruc JL, Guiraud-Chaumeil B, Clanet M.
    Rev Neurol (Paris); 1982 Feb 16; 138(5):401-8. PubMed ID: 7146724
    [Abstract] [Full Text] [Related]

  • 19. [Diurnal worsening in Parkinson patients treated with levodopa].
    Piccini P, Del Dotto P, Pardini C, D'Antonio P, Rossi G, Bonuccelli U.
    Riv Neurol; 1991 Feb 16; 61(6):219-24. PubMed ID: 1813974
    [Abstract] [Full Text] [Related]

  • 20. Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease.
    Stern GM, Lees AJ.
    Adv Neurol; 1983 Feb 16; 37():17-21. PubMed ID: 6858771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.